{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:49:56Z","timestamp":1765961396664,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Complement factor H (FH) is the main plasma regulator of the alternative pathway of complement. Genetic and acquired abnormalities in FH cause uncontrolled complement activation amplifying, with the consequent accumulation of complement components on the renal glomeruli. This leads to conditions such as C3 glomerulopathy (C3G) and atypical hemolytic uremic syndrome (aHUS). There is no effective therapy for these diseases. Half of the patients progress to end-stage renal disease and the condition recurs frequently in transplanted kidneys. Combined liver\/kidney transplantation is a valid option for these patients, but the risks of the procedure and donor organ shortages hamper its clinical application. Therefore, there is an urgent need for alternative strategies for providing a normal FH supply. Human amnion epithelial cells (hAEC) have stem cell characteristics, including the capability to differentiate into hepatocyte-like cells in vivo.<\/jats:p><jats:p>Here, we administered hAEC into the livers of newborn <jats:italic>Cfh<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> mice, which spontaneously developed glomerular complement deposition and renal lesions resembling human C3G. hAEC engrafted at low levels in the livers of <jats:italic>Cfh<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> mice and produced sufficient human FH to prevent complement activation and glomerular C3 and C9 deposition. However, long-term engraftment was not achieved, and eventually hAEC elicited a humoral immune response in immunocompetent <jats:italic>Cfh<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> mice.<\/jats:p><jats:p>hAEC cell therapy could be a valuable therapeutic option for patients undergoing kidney transplantation in whom post-transplant immunosuppression may protect allogeneic hAEC from rejection, while allogeneic cells provide normal FH to prevent disease recurrence.<\/jats:p>","DOI":"10.1186\/s13287-021-02386-7","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T14:03:08Z","timestamp":1623333788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Amnion epithelial cells are an effective source of factor H and prevent kidney complement deposition in factor H-deficient mice"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6022-2401","authenticated-orcid":false,"given":"Federica","family":"Casiraghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela Yossenaidy Rodriguez","family":"Ordonez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Azzollini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Todeschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Rottoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Donadelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Gramignoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariela","family":"Benigni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Noris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"2386_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","volume":"33","author":"M Noris","year":"2013","unstructured":"Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol. 2013;33:479\u201392 https:\/\/doi.org\/10.1016\/j.semnephrol.2013.08.001.","journal-title":"Semin Nephrol"},{"key":"2386_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0065-2776(08)04004-2","volume":"104","author":"PJ Lachmann","year":"2009","unstructured":"Lachmann PJ. The amplification loop of the complement pathways. Adv Immunol. 2009;104:115\u201349 https:\/\/doi.org\/10.1016\/S0065-2776(08)04004-2.","journal-title":"Adv Immunol"},{"key":"2386_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.molimm.2015.03.011","volume":"67","author":"RB Pouw","year":"2015","unstructured":"Pouw RB, Vredevoogd DW, Kuijpers TW, Wouters D. Of mice and men: The factor H protein family and complement regulation. Mol Immunol. 2015;67:12\u201320 https:\/\/doi.org\/10.1016\/j.molimm.2015.03.011.","journal-title":"Mol Immunol"},{"key":"2386_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2249.2007.03574.x","volume":"151","author":"MC Pickering","year":"2008","unstructured":"Pickering MC, Cook HT. Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. Clin Exp Immunol. 2008;151:210\u201330 https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03574.x.","journal-title":"Clin Exp Immunol"},{"key":"2386_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","volume":"15","author":"RJH Smith","year":"2019","unstructured":"Smith RJH, Appel GB, Blom AM, Cook HT, D\u2019Agati VD, Fakhouri F, et al. C3 glomerulopathy - understanding a rare complement-driven renal disease. Nat Rev Nephrol. 2019;15:129\u201343 https:\/\/doi.org\/10.1038\/s41581-018-0107-2.","journal-title":"Nat Rev Nephrol"},{"key":"2386_CR6","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1681\/ASN.2007030356","volume":"18","author":"RJH Smith","year":"2007","unstructured":"Smith RJH, Alexander J, Barlow PN, Botto M, Cassavant TL, Cook HT, et al. New approaches to the treatment of dense deposit disease. J Am Soc Nephrol. 2007;18:2447\u201356 https:\/\/doi.org\/10.1681\/ASN.2007030356.","journal-title":"J Am Soc Nephrol"},{"key":"2386_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1053\/j.ajkd.2018.12.046","volume":"74","author":"P Ruggenenti","year":"2019","unstructured":"Ruggenenti P, Daina E, Gennarini A, Carrara C, Gamba S, Noris M, et al. C5 convertase blockade in membranoproliferative glomerulonephritis: a single-arm clinical trial. Am J Kidney Dis. 2019;74:224\u201338 https:\/\/doi.org\/10.1053\/j.ajkd.2018.12.046.","journal-title":"Am J Kidney Dis"},{"key":"2386_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00467-015-3278-0","volume":"31","author":"R Coppo","year":"2016","unstructured":"Coppo R, Bonaudo R, Peruzzi RL, Amore A, Brunati A, Romagnoli R, et al. Liver transplantation for aHUS: still needed in the eculizumab era? Pediatr Nephrol. 2016;31:759\u201368 https:\/\/doi.org\/10.1007\/s00467-015-3278-0.","journal-title":"Pediatr Nephrol"},{"key":"2386_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1750-1172-6-60","volume":"6","author":"C Loirat","year":"2011","unstructured":"Loirat C, Fr\u00e9meaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 2011;6:60 https:\/\/doi.org\/10.1186\/1750-1172-6-60.","journal-title":"Orphanet J Rare Dis"},{"key":"2386_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/ki.2010.132","volume":"78","author":"F Fakhouri","year":"2010","unstructured":"Fakhouri F, de Jorge EG, Brune F, Azam P, Cook HT, Pickering MC. Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice. Kidney Int. 2010;78:279\u201386 https:\/\/doi.org\/10.1038\/ki.2010.132.","journal-title":"Kidney Int"},{"key":"2386_CR11","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/ki.2015.233","volume":"88","author":"E-M Nichols","year":"2015","unstructured":"Nichols E-M, Barbour TD, Pappworth IY, Wong EKS, Palmer JM, Sheerin NS, et al. An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy. Kidney Int. 2015;88:1314\u201322 https:\/\/doi.org\/10.1038\/ki.2015.233.","journal-title":"Kidney Int"},{"key":"2386_CR12","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1681\/ASN.2017091006","volume":"29","author":"Y Yang","year":"2018","unstructured":"Yang Y, Denton H, Davies OR, Smith-Jackson K, Kerr H, Herbert AP, et al. An engineered complement factor H construct for treatment of C3 glomerulopathy. J Am Soc Nephrol. 2018;29:1649\u201361 https:\/\/doi.org\/10.1681\/ASN.2017091006.","journal-title":"J Am Soc Nephrol"},{"key":"2386_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/jog.12213","volume":"40","author":"T Miki","year":"2014","unstructured":"Miki T, Grubbs B. Therapeutic potential of placenta-derived stem cells for liver diseases: current status and perspectives. J Obstet Gynaecol Res. 2014;40:360\u20138 https:\/\/doi.org\/10.1111\/jog.12213.","journal-title":"J Obstet Gynaecol Res"},{"key":"2386_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.placenta.2017.03.020","volume":"59","author":"M Fanti","year":"2017","unstructured":"Fanti M, Gramignoli R, Serra M, Cadoni E, Strom SC, Marongiu F. Differentiation of amniotic epithelial cells into various liver cell types and potential therapeutic applications. Placenta. 2017;59:139\u201345 https:\/\/doi.org\/10.1016\/j.placenta.2017.03.020.","journal-title":"Placenta"},{"key":"2386_CR15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.26150","volume":"57","author":"KJ Skvorak","year":"2013","unstructured":"Skvorak KJ, Dorko K, Marongiu F, Tahan V, Hansel MC, Gramignoli R, et al. Placental stem cell correction of murine intermediate maple syrup urine disease. Hepatology. 2013;57:1017\u201323 https:\/\/doi.org\/10.1002\/hep.26150.","journal-title":"Hepatology"},{"key":"2386_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ymgme.2013.02.011","volume":"109","author":"KJ Skvorak","year":"2013","unstructured":"Skvorak KJ, Dorko K, Marongiu F, Tahan V, Hansel MC, Gramignoli R, et al. Improved amino acid, bioenergetic metabolite and neurotransmitter profiles following human amnion epithelial cell transplant in intermediate maple syrup urine disease mice. Mol Genet Metab. 2013;109:132\u20138 https:\/\/doi.org\/10.1016\/j.ymgme.2013.02.011.","journal-title":"Mol Genet Metab"},{"key":"2386_CR17","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/sctm.16-0449","volume":"6","author":"NS Rodriguez","year":"2017","unstructured":"Rodriguez NS, Yanuaria L, Parducho KMR, Garcia IM, Varghese BA, Grubbs BH, et al. Liver-directed human amniotic epithelial cell transplantation improves systemic disease phenotype in Hurler syndrome mouse model. Stem Cells Transl Med. 2017;6:1583\u201394 https:\/\/doi.org\/10.1002\/sctm.16-0449.","journal-title":"Stem Cells Transl Med"},{"key":"2386_CR18","first-page":"333","volume":"3","author":"X Qin","year":"2006","unstructured":"Qin X, Gao B. The complement system in liver diseases. Cell Mol Immunol. 2006;3:333\u201340.","journal-title":"Cell Mol Immunol"},{"key":"2386_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/ng912","volume":"31","author":"MC Pickering","year":"2002","unstructured":"Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, Walport MJ, et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet. 2002;31:424\u20138 https:\/\/doi.org\/10.1038\/ng912.","journal-title":"Nat Genet"},{"doi-asserted-by":"publisher","unstructured":"Marongiu F, Gramignoli R, Dorko K, Miki T, Ranade AR, Paola Serra M, et al. Hepatic differentiation of amniotic epithelial cells. Hepatology (Baltimore, Md). 2011; https:\/\/doi.org\/10.1002\/hep.24255.","key":"2386_CR20","DOI":"10.1002\/hep.24255"},{"key":"2386_CR21","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1111\/jgh.12991","volume":"30","author":"JS Lin","year":"2015","unstructured":"Lin JS, Zhou L, Sagayaraj A, Jumat NHB, Choolani M, Chan JKY, et al. Hepatic differentiation of human amniotic epithelial cells and in vivo therapeutic effect on animal model of cirrhosis. J Gastroenterol Hepatol. 2015;30:1673\u201382 https:\/\/doi.org\/10.1111\/jgh.12991.","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02386-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-021-02386-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02386-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T14:08:41Z","timestamp":1623334121000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02386-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2386"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02386-7","relation":{},"ISSN":["1757-6512"],"issn-type":[{"type":"electronic","value":"1757-6512"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"assertion":[{"value":"6 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Procedures involving animals and their care conformed with institutional guidelines in compliance with national (D.lgs 26\/2014; Authorization n.19\/2008-A issued March 6, 2008 by Ministry of Health); the NIH Guide for the Care and Use of Laboratory Animals (2011 edition) and EU directives and guidelines (EEC Council Directive 2010\/63\/UE).All animal experimental protocols were approved by our Institutional Committee (IACUC, IRFMN Animal Care and Use Committee) at the Istituto di Ricerche Farmacologiche Mario Negri IRCCS, which includes \u201cad hoc\u201d members for ethical issues. Animals were housed in the Institute\u2019s Animal Care facilities, which meet international standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}